Cost per Reaction Analysis for Commercial CFPS Kits
Lysate cost and DNA template dominate cell-free protein synthesis economics.
Open formulations let scientists debug and optimize reactions that sealed kits hide.
Lysate cost and DNA template dominate cell-free protein synthesis economics.
Miniaturization and automation slash the cost of screening hundreds of protein variants.
Cell-free protein synthesis enables precise isotope labeling without metabolic interference.
Cell-free synthesis accelerates protein screening for binding studies without weeks of cell culture.
CFPS platform choice determines purification difficulty and cost before the reaction even starts.
Cell-free synthesis closes the gap between AI's design speed and experimental validation capacity.
Cell-free synthesis outperforms E. coli cultures for toxic, membrane, and eukaryotic proteins.
Extending reaction time with continuous exchange boosts milligram yields.
Lyophilized cell-free systems enable on-demand protein synthesis without living cells.
Cell-free synthesis lets researchers engineer virus-like particles faster and with precise control.